Phytotherapy as a Complementary Medicine for Multiple Sclerosis

Rabiei, Zahra

doi:10.4274/tjps.galenos.2018.90522

Cited by 8 publications

(4 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The second most cited benefit was for pain and disease management (38.5%). There is empirical support for the effectiveness of cannabis in combating chronic pain (Romero-Sandoval et al, 2018), pain associated with cancer (Bonini et al, 2018), pain associated with multiple sclerosis (Rabiei, 2019), and insomnia (Babson et al, 2017;Klumpers & Thacker, 2019). Recent research found support for the beneficial effects of cannabis on depression (Premoli et al, 2019;Silote et al, 2019), PTSD (Ney et al, 2019), and irritable bowels (Couch et al, 2018).…”

Section: Discussionmentioning

confidence: 99%

“…The use of cannabis to address pain, seizures, nausea, sleep disturbance, and loss of appetite has been the most conclusive. Analgesic effects (Bonini et al, 2018;Klumpers & Thacker, 2019;Rabiei, 2019;Romero-Sandoval et al, 2018;Wilkie et al, 2016), anticonvulsant effects (Bonini et al, 2018;Klumpers & Thacker, 2019;Premoli et al, 2019), and antiemetic effects (Bonini et al, 2018;Klumpers & Thacker, 2019;Premoli et al, 2019) have been documented. Circadian regulation effects have been found to be effective in addressing various types of sleep disturbance (Babson et al, 2017;Klumpers & Thacker, 2019).…”

Section: Cannabis and Healthmentioning

confidence: 99%

See 1 more Smart Citation

Marijuana Use and Achievement Motives: An Exploratory Analysis of Self-Reported Health Among Adult Cannabis Consumers

Gould

Greene

Donnelly

2020

Journal of Drug Issues

View full text Add to dashboard Cite

The purpose of this study was to explore self-reported physical health and achievement motives in a sample of adult cannabis consumers. An online target sample ( n = 181) of adult cannabis consumers ( M = 38 yoa) was obtained from a cannabis tourism company in Colorado. Physical health and the primary benefit of cannabis use were self-reported and achievement motives were measured using the revised 10-item version of the Achievement Motives Scale (AMS). Results revealed five categories of benefit from cannabis consumption: stress/anxiety reduction (40%), pain/disease management (38.5%), thinking/introspection (11%), alternative drug (7.1%), and enhanced sociability (3%). t test results revealed no significant differences between the stress/anxiety and pain/disease groups in self-reported health (SRH), AMS dimensions, or cannabis consumption preferences. Regression results revealed that AMS factor fear of failure ( b = −0.224, p = .003), followed by cannabis spending per week ( b = −0.217, p = .024) best predicted SRH.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Cannabis and Healthmentioning

confidence: 99%

Marijuana Use and Achievement Motives: An Exploratory Analysis of Self-Reported Health Among Adult Cannabis Consumers

Gould

Greene

Donnelly

2020

Journal of Drug Issues

View full text Add to dashboard Cite

show abstract

“…The sedative and antidepressant effects of phytotherapy, along with improvements in sleep quality, decreases in muscle rigidity, neuropathic pain, and the degree of pelvic organ dysfunction have drawn attention. 35 A positive therapeutic effect was also noted with the use of plant polyphenols, which include chrysin extracted from the plant Passiflora caerulea. Chrysin has antioxidant, anti-inflammatory and neuroprotective effects.…”

Section: Phytotherapymentioning

confidence: 99%

The Value of Traditional Medicine Should not be Underestimated—Traditional Chinese Medicine in Treatment of Autoimmune Diseases

Novikov,

Akopyan

2024

Chinese Medicine and Culture

View full text Add to dashboard Cite

Autoimmune diseases of the nervous system (ADNS) are characterized by the formation of a pronounced neurologic deficit and often lead to disability. The attention of doctors and researchers is increasingly attracted by complementary medicine as adjuvant or preventive therapy for various diseases, including autoimmune diseases. Traditional Chinese medicine (TCM) is a combination of treatment methods that include acupuncture, herbal medicine, dietetics, physical exercises, and other methods that are often used in conjunction with recognized approaches of official medical science. The article describes the application of TCM techniques in autoimmune diseases of the nervous system, and demonstrates clinical experience in the use of acupuncture, herbal medicine, diets and physical exercises. Traditional and complementary medicine is an important and often underestimated healthcare resource, especially in the prevention and treatment of autoimmune diseases of the nervous system.

show abstract

“…It causes significant multifocal demyelination in both gray and white matter, and axonal damage via an autoimmune mechanism directly linked to neuroinflammation [161]. The stimulation of the immune system is not completely understood [162], but it is believed that both genetic and environmental factors are the main triggers [12].…”

Section: Cannabinoids and Multiple Sclerosismentioning

confidence: 99%

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

Vasincu

Rusu

Ababei

et al. 2022

Biology

View full text Add to dashboard Cite

Neurodegenerative diseases are an increasing cause of global morbidity and mortality. They occur in the central nervous system (CNS) and lead to functional and mental impairment due to loss of neurons. Recent evidence highlights the link between neurodegenerative and inflammatory diseases of the CNS. These are typically associated with several neurological disorders. These diseases have fundamental differences regarding their underlying physiology and clinical manifestations, although there are aspects that overlap. The endocannabinoid system (ECS) is comprised of receptors (type-1 (CB1R) and type-2 (CB2R) cannabinoid-receptors, as well as transient receptor potential vanilloid 1 (TRPV1)), endogenous ligands and enzymes that synthesize and degrade endocannabinoids (ECBs). Recent studies revealed the involvement of the ECS in different pathological aspects of these neurodegenerative disorders. The present review will explore the roles of cannabinoid receptors (CBRs) and pharmacological agents that modulate CBRs or ECS activity with reference to Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Huntington’s Disease (HD) and multiple sclerosis (MS).

show abstract

Phytotherapy as a Complementary Medicine for Multiple Sclerosis

Cited by 8 publications

References 44 publications

Marijuana Use and Achievement Motives: An Exploratory Analysis of Self-Reported Health Among Adult Cannabis Consumers

Marijuana Use and Achievement Motives: An Exploratory Analysis of Self-Reported Health Among Adult Cannabis Consumers

The Value of Traditional Medicine Should not be Underestimated—Traditional Chinese Medicine in Treatment of Autoimmune Diseases

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

Contact Info

Product

Resources

About